Literature DB >> 7224720

Pharmacokinetics of etomidate in surgical patients.

G de Ruiter, D T Popescu, A G de Boer, J B Smeekens, D D Breimer.   

Abstract

Eight adult surgical patients received a single i.v. injection of etomidate-base (mean 0.22 mg.kg(-1)). Venous blood samples were drawn at frequent intervals for up to 10 hr following drug administration. Plasma concentrations of etomidate were measured with a newly developed capillary gas chromatographic method. Plasma concentrations fitted best to an open three compartment pharmacokinetic model by a non-linear regression computer programme. The following mean parameters were computed: distribution half-life 2.8 + or - 2.3 min, half-life of the alpha-phase: 22.3 +or - 10.4 min and half-life of the beta-phase 208.8 + or - 64.9 min, distribution volume 3.68 + or - 0.66 l.kg(-1) (Vd area) and 2.16 l.kg(-1) (Vdss) and plasma clearance 879 + or - 135 ml.min(-1). High tissue uptake is indicated by the rapidity and the large volume of distribution. Etomidate is rapidly redistributed from the central to peripheral compartments and rapidly eliminated by metabolism.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7224720

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  8 in total

1.  Inhibition by anaesthetics of 14C-guanidinium flux through the voltage-gated sodium channel and the cation channel of the 5-HT3 receptor of N1E-115 neuroblastoma cells.

Authors:  M Barann; M Göthert; K Fink; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-02       Impact factor: 3.000

Review 2.  Intravenous anaesthetic agents. Pharmacokinetic-pharmacodynamic relationships.

Authors:  B N Swerdlow; F O Holley
Journal:  Clin Pharmacokinet       Date:  1987-02       Impact factor: 6.447

Review 3.  Medical suppression of hypercortisolemia in Cushing's syndrome with particular consideration of etomidate.

Authors:  Jens Heyn; Carolin Geiger; Christian L Hinske; Josef Briegel; Florian Weis
Journal:  Pituitary       Date:  2012-06       Impact factor: 4.107

4.  Methoxycarbonyl-etomidate: a novel rapidly metabolized and ultra-short-acting etomidate analogue that does not produce prolonged adrenocortical suppression.

Authors:  Joseph F Cotten; S Shaukat Husain; Stuart A Forman; Keith W Miller; Elizabeth W Kelly; Hieu H Nguyen; Douglas E Raines
Journal:  Anesthesiology       Date:  2009-08       Impact factor: 7.892

Review 5.  Clinical pharmacokinetic considerations in the treatment of increased intracranial pressure.

Authors:  G Heinemeyer
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

6.  Kinetics of nicotinic acetylcholine ion channels in the presence of intravenous anaesthetics and induction agents.

Authors:  R E Wachtel; E S Wegrzynowicz
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

7.  Effects of etomidate on cortisol biosynthesis in isolated guinea-pig adrenal cells: comparison with metyrapone.

Authors:  R De Coster; D Beerens; C Haelterman; L Wouters
Journal:  J Endocrinol Invest       Date:  1985-06       Impact factor: 4.256

Review 8.  Etomidate and its Analogs: A Review of Pharmacokinetics and Pharmacodynamics.

Authors:  Beatrijs I Valk; Michel M R F Struys
Journal:  Clin Pharmacokinet       Date:  2021-06-01       Impact factor: 6.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.